DK1140115T3 - Phospholipidkomplekser af proanthocyanidin A2 som antiatherosclerotiske midler - Google Patents

Phospholipidkomplekser af proanthocyanidin A2 som antiatherosclerotiske midler

Info

Publication number
DK1140115T3
DK1140115T3 DK99966956T DK99966956T DK1140115T3 DK 1140115 T3 DK1140115 T3 DK 1140115T3 DK 99966956 T DK99966956 T DK 99966956T DK 99966956 T DK99966956 T DK 99966956T DK 1140115 T3 DK1140115 T3 DK 1140115T3
Authority
DK
Denmark
Prior art keywords
proanthocyanidin
phospholipid complexes
antiatherosclerotic agents
complexes
phospholipids
Prior art date
Application number
DK99966956T
Other languages
Danish (da)
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK1140115T3 publication Critical patent/DK1140115T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544Phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
DK99966956T 1998-12-18 1999-12-13 Phospholipidkomplekser af proanthocyanidin A2 som antiatherosclerotiske midler DK1140115T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002732A IT1304183B1 (it) 1998-12-18 1998-12-18 Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
PCT/EP1999/009854 WO2000037062A2 (en) 1998-12-18 1999-12-13 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents

Publications (1)

Publication Number Publication Date
DK1140115T3 true DK1140115T3 (da) 2003-08-25

Family

ID=11381268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99966956T DK1140115T3 (da) 1998-12-18 1999-12-13 Phospholipidkomplekser af proanthocyanidin A2 som antiatherosclerotiske midler

Country Status (22)

Country Link
US (1) US6429202B1 (it)
EP (1) EP1140115B1 (it)
JP (1) JP4842436B2 (it)
KR (1) KR100694907B1 (it)
CN (1) CN1146429C (it)
AT (1) ATE238803T1 (it)
AU (1) AU763907B2 (it)
CA (1) CA2355776C (it)
CZ (1) CZ301495B6 (it)
DE (1) DE69907509T2 (it)
DK (1) DK1140115T3 (it)
ES (1) ES2197708T3 (it)
HK (1) HK1042430B (it)
HU (1) HU228928B1 (it)
IL (2) IL143751A0 (it)
IT (1) IT1304183B1 (it)
NO (1) NO328733B1 (it)
PL (1) PL197153B1 (it)
PT (1) PT1140115E (it)
RU (1) RU2248798C2 (it)
SK (1) SK284884B6 (it)
WO (1) WO2000037062A2 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8507018B2 (en) * 1998-03-12 2013-08-13 Mars, Incorporated Products containing polyphenol(s) and L-arginine and methods of use thereof
AU2003226974A1 (en) * 2002-02-12 2003-09-04 Hunza Di Pistolesi Elvira And C. S.A.S. N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
AU2005209317B2 (en) * 2004-01-28 2011-07-07 Mars, Incorporated Compositions and methods of use of A-type procyanidins
EP1837030A1 (en) 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability
JP5443015B2 (ja) * 2008-02-19 2014-03-19 株式会社岐阜セラツク製造所 医薬組成物
IT1398624B1 (it) * 2009-02-02 2013-03-08 Dermogyn S R L Uso cosmetico della proantocianidina a2
RU2456674C1 (ru) * 2011-05-31 2012-07-20 Тагир Уралович Гафаров Способ моделирования атрофического рубца кожи
CN102688501A (zh) * 2012-06-20 2012-09-26 浙江萧山医院 原花青素b2磷脂复合物及其制备方法和用途
CN103120798A (zh) * 2013-01-10 2013-05-29 施冬云 一种具有抗氧化应激作用的磷脂复合物制备方法及其应用
CN103467778B (zh) * 2013-09-06 2015-09-30 天津大学 细菌纤维素/卵磷脂复合材料及制备和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
US5648377A (en) * 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
IT1270999B (it) * 1994-07-26 1997-05-26 Indena Spa Formulazioni a base di cumarine e loro uso in campo farmaceutico e cosmetico
FI955691A (fi) * 1994-11-28 1996-05-29 Suntory Ltd Lipoproteiini(a):ta alentava aine, kolesterolia alentava aine ja näitä aineita sisältävät lääkkeet
IT1296920B1 (it) * 1997-12-04 1999-08-03 Indena Spa Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
EP1210785B1 (de) 1999-09-08 2005-11-23 Siemens Aktiengesellschaft Anordnung und verfahren für eine optische informationsübertragung

Also Published As

Publication number Publication date
PT1140115E (pt) 2003-08-29
SK284884B6 (sk) 2006-02-02
WO2000037062A2 (en) 2000-06-29
IL143751A0 (en) 2002-04-21
WO2000037062A3 (en) 2000-08-03
US6429202B1 (en) 2002-08-06
IT1304183B1 (it) 2001-03-08
CA2355776A1 (en) 2000-06-29
CA2355776C (en) 2008-03-18
CN1146429C (zh) 2004-04-21
AU763907B2 (en) 2003-08-07
NO20012944D0 (no) 2001-06-14
ITMI982732A1 (it) 2000-06-18
IL143751A (en) 2006-07-05
SK8602001A3 (en) 2001-12-03
JP4842436B2 (ja) 2011-12-21
DE69907509T2 (de) 2004-04-08
HUP0104665A2 (hu) 2002-04-29
ES2197708T3 (es) 2004-01-01
PL197153B1 (pl) 2008-03-31
NO328733B1 (no) 2010-05-03
JP2002532543A (ja) 2002-10-02
CN1330548A (zh) 2002-01-09
KR100694907B1 (ko) 2007-03-14
NO20012944L (no) 2001-06-14
EP1140115B1 (en) 2003-05-02
HK1042430A1 (en) 2002-08-16
HU228928B1 (en) 2013-06-28
HUP0104665A3 (en) 2003-01-28
EP1140115A2 (en) 2001-10-10
CZ301495B6 (cs) 2010-03-24
AU2283000A (en) 2000-07-12
HK1042430B (zh) 2004-10-08
ATE238803T1 (de) 2003-05-15
CZ20012134A3 (cs) 2001-12-12
DE69907509D1 (en) 2003-06-05
RU2248798C2 (ru) 2005-03-27
KR20010093826A (ko) 2001-10-29

Similar Documents

Publication Publication Date Title
TR200103186T2 (tr) MEK enzimlerinin inhibitörleri olarak kinolin türevleri
ES2189235T3 (es) 6-fenilfenantridinas sustituidas.
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
ATE429210T1 (de) Orale flüssige zusammensetzungen
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
TR200100047T2 (tr) Tiyobenzimidazol türevleri
DK1140115T3 (da) Phospholipidkomplekser af proanthocyanidin A2 som antiatherosclerotiske midler
TNSN98203A1 (fr) Derives de thienopyrimidine et tienopyridine utiles comme agents anticancereux, et compositions les contenant
TR200402656T4 (tr) Antikanser ajanları olarak faydalı tiyofen türevleri
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
BR0008176A (pt) Derivados anti-convulsivantes úteis no tratamento de cefaléias em cacho
ATE424835T1 (de) Methoden zur erhöhung der wirksamkeit von nicht- steroidalen antientzündlichen arzneien und dazu verwendbare zusammensetzungen enthaltend zwitterionische phospholipide
BR0107147A (pt) Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
DE69710065D1 (de) Androsten-derivate
ATE258802T1 (de) Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
NO20040821L (no) 3-substituerte 6,7-dihydroksytetrahydroisokinolinderivater for andvendelse som antibakterielle midler.
RS11104A (en) Combined preparations,containing 1,4- benzothiepine-1,1- dioxide derivatives and other active substances, and the use thereof
ATE299027T1 (de) Verwendung von übersulfatierten polysacchariden als hiv-hemmer
IL139317A0 (en) Benzimdazole and benzoxazole derivatives and pharmaceutical compositions contining the same
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto